You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Details for Patent: 8,299,209


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,299,209 protect, and when does it expire?

Patent 8,299,209 protects SIGNIFOR and is included in one NDA.

This patent has forty-two patent family members in thirty-five countries.

Summary for Patent: 8,299,209
Title:Pharmaceutical composition comprising cyclic somatostatin analogues
Abstract: Pharmaceutical compositions comprising a somastatin analogue in the form of a liquid formulation for parenteral administration are disclosed.
Inventor(s): Lambert; Olivier (Spechbach-le-Haut, FR), Moser; Katrin (Brookline, MA)
Assignee: Novartis AG (Basel, CH)
Application Number:12/359,527
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,299,209: A Comprehensive Analysis

Introduction

United States Patent 8,299,209, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To fully grasp the implications and significance of this patent, it is crucial to delve into its various components and the broader patent landscape.

Patent Basics

What is a Patent?

A patent is a form of intellectual property that grants the inventor exclusive rights to make, use, and sell the invention for a specified period, typically 20 years from the filing date of the patent application[2].

Types of Patents

There are several types of patents, including utility patents, design patents, and plant patents. Utility patents, which are the most common, cover functional inventions and are likely the category under which U.S. Patent 8,299,209 falls.

The Patent Document

Structure of a Patent Document

A patent document typically includes several key sections:

  • Background of the Invention: Provides context and prior art related to the invention.
  • Summary of the Invention: A brief overview of the invention.
  • Detailed Description of the Invention: A detailed explanation of the invention, including drawings and diagrams.
  • Claims: The most critical part, as these define the scope of protection for the invention[4].

Claims Analysis

Importance of Claims

The claims section is the heart of any patent document. It outlines what the inventor is seeking to protect and defines the boundaries of the invention. Claims can be independent or dependent, with dependent claims building upon independent claims[3].

Claim Types

  • Independent Claims: Standalone claims that define the invention without reference to other claims.
  • Dependent Claims: Claims that refer back to and further limit an independent claim.

Claim Scope

The scope of the claims determines what is protected by the patent. Broad claims may cover a wide range of variations, while narrow claims are more specific and limited. The balance between broad and narrow claims is crucial for effective patent protection.

Scope of Protection

Determining Scope

The scope of protection for U.S. Patent 8,299,209 is defined by its claims. To understand this scope, one must carefully analyze each claim, considering both the independent and dependent claims.

Patent Scope Measurements

The USPTO provides tools and datasets to help analyze patent scope. For example, the Patent Claims Research Dataset offers detailed information on claims from U.S. patents, including claim-level statistics and document-level statistics, which can help in understanding the scope of a patent[3].

Inventorship and Ownership

Determining Inventorship

Inventorship is a critical aspect of patent law. The true and only inventors must be listed on the patent application. Incorrect or incomplete identification of inventors can lead to the patent being invalidated[2].

Ownership Implications

The ownership of a patent can be complex, especially when inventors are employed by different organizations or when there are disputes over inventorship. Correct determination of inventorship is essential to avoid legal issues and ensure the patent remains enforceable.

Obviousness-Type Double Patenting (ODP)

What is ODP?

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is obvious in view of a previously granted patent. This is particularly relevant when dealing with continuation-in-part patents or patents with different patent terms due to Patent Term Adjustment (PTA)[1].

Impact on Patent Term

In cases where PTA is granted, the ODP analysis must consider the adjusted expiration date of the patent. This ensures that the inventor does not extend the term of the patent beyond what is legally permissible[1].

Patent Landscape and Global Considerations

Global Dossier

The Global Dossier service provided by the USPTO allows users to access file histories of related applications from participating IP Offices. This can be useful in understanding the global patent landscape and how a patent like U.S. Patent 8,299,209 fits into it[4].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could impact how patent disputes, including those related to U.S. Patent 8,299,209, are handled. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes[5].

Key Takeaways

  • Claims Define Scope: The claims section of a patent document is crucial for understanding what is protected.
  • Inventorship Matters: Correct identification of inventors is essential for the validity and enforceability of a patent.
  • ODP Considerations: Obviousness-type double patenting must be considered, especially in cases involving PTA.
  • Global Implications: Understanding the global patent landscape can provide insights into the broader implications of a patent.
  • Dispute Resolution: The potential for a small claims patent court could change how patent disputes are resolved.

FAQs

What is the significance of the claims section in a patent document?

The claims section defines the scope of protection for the invention, outlining what the inventor is seeking to protect.

How does incorrect inventorship affect a patent?

Incorrect or incomplete identification of inventors can lead to the patent being invalidated, making it unenforceable.

What is obviousness-type double patenting (ODP)?

ODP prevents an inventor from securing a second, later-expiring patent for an invention that is obvious in view of a previously granted patent.

How does Patent Term Adjustment (PTA) affect ODP analysis?

PTA must be considered in ODP analysis, with the analysis based on the adjusted expiration date of the patent.

What is the Global Dossier service?

The Global Dossier service allows users to access file histories of related applications from participating IP Offices, providing a comprehensive view of the global patent landscape.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. Determining Inventorship for US Patent Applications - Oregon State University
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States (ACUS)

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,299,209

Showing 1 to 3 of 3 entries

Foreign Priority and PCT Information for Patent: 8,299,209

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0314695.8Jun 24, 2003
United Kingdom0325388.7Oct 30, 2004

International Family Members for US Patent 8,299,209

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 044852 ⤷  Try for Free
European Patent Office 1648934 ⤷  Try for Free PA2012016 Lithuania ⤷  Try for Free
European Patent Office 1648934 ⤷  Try for Free C20120019 00062 Estonia ⤷  Try for Free
European Patent Office 1648934 ⤷  Try for Free PA2012016,C1648934 Lithuania ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.